Stanley Prusiner
(1942 - )
Stanley B. Prusiner was born in Des Moines, Iowa on May 28, 1942. Prusiner attended the University of
Pennsylvania. Prusiner received both his undergraduate
degree in Chemistry and his M.D. from Penn. Prusiner
then completed an internship in medicine at UCSF. From
there, Prusiner went to the National Institutes of Health,
where he studied glutaminases in E. coli in the laboratory
of Earl Stadtman. In 1972, Prusiner returned to University
of California at San Francisco to complete a residency
in Neurology. Upon completion of that residency in 1974,
Prusiner joined the faculty of the Neurology department
at UCSF. Prusiner is a Professor of Neurology and Biochemistry
at the University of California, San Francisco.
He received the Albert Lasker Award for Basic Medical
Research in 1994 and was awarded the Nobel
Prize in physiology or medicine in 1997 for his
discovery of prions, a class of infectious self-reproducing
agents composed of protein.
The following press release from the Royal Swedish
Academy of Sciences describes Prusiner's work:
The 1997 Nobel Prize in Physiology or Medicine is awarded
to the American Stanley Prusiner for his pioneering
discovery of an entirely new genre of disease-causing
agents and the elucidation of the underlying priciples
of their mode of action. Stanley Prusiner has added
prions to the list of well known infectious agents including
bacteria, viruses, fungi and parasites. Prions exist
normally as innocuous cellular proteins, however, prions
possess an innate capacity to convert their structures
into highly stabile conformations that ultimately result
in the formation of harmful particles, the causative
agents of several deadly brain diseases of the dementia
type in humans and animals. Prion diseases may be inherited,
laterally transmitted, or occur spontaneously. Regions
within diseased brains have a characteristic porous
and spongy appearance, evidence of extensive nerve cell
death, and affected individuals exhibit neurological
symptoms including impaired muscle control, loss of
mental acuity, memory loss and insomnia. Stanley Prusiner's
discovery provides important insights that may furnish
the basis to understand the biological mechanisms underlying
other types of dementia-related diseases, for example
Alzheimer's disease, and establishes a foundation for
drug development and new types of medical treatment
strategies.
Sources: Wikipedia,
Nobelprize.org,
Nobel
Prize Autobiography |